Concepedia

Andrew P. Chapman

AP

Statistics

Publications

8

Citations

1.4K

H-Index

8

Active since

1997

Affiliations

UCB Pharma (United Kingdom)(Current)

Macquarie University

Andrew P. Chapman is an author at UCB Pharma (United Kingdom) specializing in life sciences, protein engineering, and biochemistry.

Publications per year

1997–2001

8

Publications

8

Predictive accuracy of population viability analysis in conservation biology

Barry W. Brook, Julian J. O’Grady, Andrew P. Chapman et al. · Nature · 2000 · 731 citations

, , +15

Therapeutic antibody fragments with prolonged in vivo half-lives

Andrew P. Chapman, Pari Antoniw, Mariangela Spitali et al. · Nature Biotechnology · 1999 · 348 citations

, , +14

Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin

Bryan John Smith, Andrew G. Popplewell, Dee Athwal et al. · Bioconjugate Chemistry · 2001 · 92 citations

, , +17

High-Level Periplasmic Expression in Escherichia coli Using a Eukaryotic Signal Peptide: Importance of Codon Usage at the 5′ End of the Coding Sequence

David P. Humphreys, Mukesh Sehdev, Andrew P. Chapman et al. · Protein Expression and Purification · 2000 · 69 citations

, , +17

Population viability analyses on a cycling population: a cautionary tale

Andrew P. Chapman, Barry W. Brook, Tim Clutton‐Brock et al. · Biological Conservation · 2001 · 39 citations

, , +12

1–5 of 8